This page includes information on the European Medicines Agency's minor-use-minor-species (MUMS) / limited-market policy.
This policy is intended to assist applicants with submitting applications for products for limited markets, to stimulate development of new veterinary medicines for minor species and for rare diseases in major species which would otherwise not be developed in the current market conditions.
The policy was first introduced in October 2010 and has been successful in terms of increasing interest from the animal-health industry in submitting applications for MUMS products.
In June 2013, the Agency revised the policy, so that only products indicated for food-producing species will be eligible for fee incentives in the future.
Scientific guidance documents on this topic can be found in the relevant section under scientific guidance.
Table of contents
European Task Force on Availability
|Document(s)||Language||Status||First published||Last updated||Effective Date|
|Fourth annual report veterinary - Minor uses / minor species and limited market||(English only)||adopted||25/03/2014|
|Minutes of the European Task Force on Availability of Medicines fourth meeting - 20 June 2000||(English only)||06/07/2000||06/07/2000|
|Minutes of the European Task Force on Availability of Medicines third meeting - 7 March 2000||(English only)||08/03/2000||08/03/2000|
|Minutes of the European Task Force on Availability of Medicines second meeting - 7 December 1999||(English only)||18/01/2000||18/01/2000|
|Minutes of the European Task Force on Availability of Medicines first meeting - 14 October 1999||(English only)||13/12/1999||13/12/1999|